S&CO Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.21M | Hold |
50,218
| – | – | 0.07% | 135 |
|
|
2026
Q1 | $1.41M | Sell |
50,218
-3,270
| -6% | -$87.1K | 0.09% | 126 |
|
|
2025
Q4 | $1.33M | Sell |
53,488
-1,906
| -3% | -$48.1K | 0.08% | 131 |
|
|
2025
Q3 | $1.41M | Sell |
55,394
-2,255
| -4% | -$55.7K | 0.09% | 127 |
|
|
2025
Q2 | $1.4M | Sell |
57,649
-1,100
| -2% | -$25.7K | 0.09% | 133 |
|
|
2025
Q1 | $1.49M | Buy |
58,749
+47,049
| +402% | +$1.23M | 0.1% | 123 |
|
|
2024
Q4 | $310K | Hold |
11,700
| – | – | 0.02% | 183 |
|
|
2024
Q3 | $338K | Hold |
11,700
| – | – | 0.02% | 187 |
|
|
2024
Q2 | $327K | Sell |
11,700
-18,998
| -62% | -$523K | 0.02% | 187 |
|
|
2024
Q1 | $851K | Sell |
30,698
-8,618
| -22% | -$239K | 0.06% | 145 |
|
|
2023
Q4 | $1.13M | Sell |
39,316
-3,500
| -8% | -$106K | 0.09% | 120 |
|
|
2023
Q3 | $1.42M | Buy |
42,816
+1,400
| +3% | +$49.5K | 0.12% | 105 |
|
|
2023
Q2 | $1.52M | Buy |
41,416
+8,487
| +26% | +$330K | 0.12% | 102 |
|
|
2023
Q1 | $1.34M | Sell |
32,929
-1,645
| -5% | -$71K | 0.11% | 104 |
|
|
2022
Q4 | $1.77M | Buy |
34,574
+304
| +0.9% | +$14.6K | 0.16% | 89 |
|
|
2022
Q3 | $1.5M | Buy |
34,270
+150
| +0.4% | +$7.29K | 0.14% | 99 |
|
|
2022
Q2 | $1.79M | Buy |
34,120
+400
| +1% | +$20.4K | 0.15% | 94 |
|
|
2022
Q1 | $1.75M | Hold |
33,720
| – | – | 0.12% | 101 |
|
|
2021
Q4 | $1.99M | Hold |
33,720
| – | – | 0.14% | 99 |
|
|
2021
Q3 | $1.45M | Buy |
33,720
+120
| +0.4% | +$5.32K | 0.11% | 105 |
|
|
2021
Q2 | $1.31M | Buy |
33,600
+210
| +0.6% | +$8.17K | 0.1% | 110 |
|
|
2021
Q1 | $1.21M | Buy |
33,390
+7,135
| +27% | +$253K | 0.1% | 110 |
|
|
2020
Q4 | $966K | Sell |
26,255
-4,249
| -14% | -$156K | 0.09% | 120 |
|
|
2020
Q3 | $1.06M | Hold |
30,504
| – | – | 0.11% | 111 |
|
|
2020
Q2 | $946K | Hold |
30,504
| – | – | 0.1% | 110 |
|
|
2020
Q1 | $945K | Hold |
30,504
| – | – | 0.13% | 97 |
|
|
2019
Q4 | $1.13M | Hold |
30,504
| – | – | 0.12% | 99 |
|
|
2019
Q3 | $1.04M | Hold |
30,504
| – | – | 0.12% | 105 |
|
|
2019
Q2 | $1.25M | Hold |
30,504
| – | – | 0.14% | 97 |
|
|
2019
Q1 | $1.23M | Hold |
30,504
| – | – | 0.14% | 97 |
|
|
2018
Q4 | $1.26M | Hold |
30,504
| – | – | 0.16% | 88 |
|
|
2018
Q3 | $1.27M | Sell |
30,504
-2,424
| -7% | -$93.3K | 0.14% | 95 |
|
|
2018
Q2 | $1.13M | Buy |
32,928
+316
| +1% | +$10.8K | 0.14% | 98 |
|
|
2018
Q1 | $1.1M | Buy |
32,612
+2,271
| +7% | +$78.1K | 0.14% | 98 |
|
|
2017
Q4 | $1.04M | Hold |
30,341
| – | – | 0.13% | 100 |
|
|
2017
Q3 | $1.03M | Hold |
30,341
| – | – | 0.13% | 99 |
|
|
2017
Q2 | $967K | Hold |
30,341
| – | – | 0.13% | 97 |
|
|
2017
Q1 | $985K | Hold |
30,341
| – | – | 0.13% | 97 |
|
|
2016
Q4 | $935K | Buy |
30,341
+3,162
| +12% | +$96.5K | 0.14% | 94 |
|
|
2016
Q3 | $873K | Hold |
27,179
| – | – | 0.13% | 99 |
|
|
2016
Q2 | $908K | Buy |
27,179
+1,438
| +6% | +$45.9K | 0.14% | 97 |
|
|
2016
Q1 | $724K | Hold |
25,741
| – | – | 0.12% | 103 |
|
|
2015
Q4 | $788K | Hold |
25,741
| – | – | 0.13% | 99 |
|
|
2015
Q3 | $767K | Hold |
25,741
| – | – | 0.13% | 98 |
|
|
2015
Q2 | $819K | Hold |
25,741
| – | – | 0.12% | 102 |
|
|
2015
Q1 | $850K | Hold |
25,741
| – | – | 0.12% | 98 |
|
|
2014
Q4 | $761K | Hold |
25,741
| – | – | 0.11% | 102 |
|
|
2014
Q3 | $722K | Hold |
25,741
| – | – | 0.11% | 97 |
|
|
2014
Q2 | $725K | Hold |
25,741
| – | – | 0.1% | 94 |
|
|
2014
Q1 | $784K | Hold |
25,741
| – | – | 0.12% | 85 |
|
|
2013
Q4 | $748K | Hold |
25,741
| – | – | 0.13% | 81 |
|
|
2013
Q3 | $702K | Sell |
25,741
-8,198
| -24% | -$223K | 0.12% | 85 |
|
|
2013
Q2 | $902K | Buy |
+33,939
| New | +$938K | 0.14% | 76 |
|
Other funds holding PFE
S&CO Inc's PFE Position: Q2 2026 in Review
S&CO Inc held its Pfizer (PFE) position steady in Q2 2026 at 50,218 shares worth $1.21M. The position accounts for 0.07% of the portfolio, ranked #135.
S&CO Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.99M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- S&CO Inc held 50,218 shares of Pfizer worth $1.21M as of Q2 2026.
- S&CO Inc left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.07% of S&CO Inc's portfolio in Q2 2026, its #135 holding.
- S&CO Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- S&CO Inc's Pfizer position peaked at $1.99M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on S&CO Inc's 13F filing for Q2 2026, filed 6 Aug 2026.